Valor202020212022202320242025TTMGastos comerciales, generales y administrativos731.32 M1.5 B1.3 B1.25 B1.33 B1.41 B1.41 BInvestigación y desarrollo66.33 M87.94 M101.58 M103.68 M107.65 M112.9 M112.9 MBeneficio operativo548.37 M425.62 M268.19 M836.12 M866.64 M1.1 B1.1 BTotal de ingresos no operativos-30.84 M-111.11 M-110.84 M-133.31 M-70.43 M-54.4 M-54.4 MGastos por intereses, netos de intereses capitalizados37.18 M89.59 M107.99 M144.35 M86.26 M60.7 M60.7 MIngresos no operativos, una vez deducidos los gastos por intereses-74.36 M-206.99 M-215.98 M-288.7 M-78.84 M-124.9 M-79.2 MIngresos/gastos extraordinarios6.34 M6.28 M-2.85 M11.04 M8.4 M9.8 M9.8 MBeneficio antes de impuestos517.53 M314.5 M157.35 M702.81 M796.21 M1.05 B1.05 BParticipación en los beneficios———————Impuestos120.66 M71.63 M51.53 M149.53 M184.65 M262.2 M262.2 MParticipación minoritaria-530 K-1.02 M-1.22 M1.84 M1.43 M2.8 M2.8 MOtros ingresos/gastos después de impuestos-24.27 M21.64 M24.83 M-12.32 M3.75 M5.6 M5.6 MBeneficio neto antes de actividades interrumpidas397.4 M243.89 M107.03 M551.44 M610.12 M782.3 M782.3 MOperaciones suspendidas———-173.2 M4.52 M00Beneficio neto397.4 M243.89 M107.03 M378.24 M614.64 M782.3 M782.3 MAjuste por dilución———————Dividendos de las acciones preferentes———————Beneficio neto diluido atribuible a los accionistas397.4 M243.89 M107.03 M378.24 M614.64 M782.3 M782.3 MBeneficio básico por acción4.662.51.073.836.247.977.97Beneficio por acción diluido4.632.481.073.816.27.937.93Número medio de acciones ordinarias85.2 M97.53 M99.71 M98.79 M98.58 M98.2 M—Acciones diluidas85.9 M98.33 M100.25 M99.36 M99.07 M98.7 M—EBITDA767.61 M978.72 M821.08 M1.4 B1.34 B1.59 B2.48 BEBIT548.37 M425.62 M268.19 M836.12 M866.64 M1.1 B1.99 BCosto de los ingresos1.76 B2.57 B2.8 B2.92 B3.06 B3.31 B—Otros costes de producción———————Amortización y depreciación (flujo de caja)219.24 M553.1 M552.9 M565.24 M476.21 M486.5 M486.5 M
STERIS plc Ordinary Shares
Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018.
Steris is listed on the New York Stock Exchange, and is a constituent of the S&P 500 Index. As of 2024, the President and CEO is Daniel A. Carestio.